Cutaneous and bony metastases as a presentation of a breast carcinoma

Authors

  • Ever M Olivera Fonseca Hospital Universitario Calixto García. La Habana, Ciudad Habana
  • Yanelys Olivera Fonseca Filial de Ciencias Médicas Efraín Benítez Popa. Bayamo. Granma
  • Imilce Tamayo Ponce Hospital Universitario Calixto García. La Habana, Ciudad Habana
  • Margarita Millán Vega Hospital Provincial Carlos Manuel de Céspedes. Bayamo. Granma

Keywords:

breast neoplasms, lobular carcinoma, skin neoplasms, bone neoplasms, neoplasm metastasis.

Abstract

Invasive breast cancer is the most frequent tumor in women and is the leading cause of cancer death in this sex worldwide. Metastatic breast cancer causes more than half a million deaths worldwide each year. Eventually any malignancy can metastasize to the skin, but in women, the mammary origin is the most frequent, represent between 1 % and 5 % and may be the first or only clinical sign of a hidden tumor. They present as single or multiple lesions, asymptomatic and of varied clinical appearance. On the other hand, bone metastases are a common cause of morbidity in patients with malignant tumors. The pain that affects patients with advanced injuries is mainly caused by them. Almost all malignant lesions produce bone metastases, although those of the breast, lung and prostate represent more than 80 % of cases. We present the case of a 49-year-old female patient with cutaneous and bone metastases from a lobular carcinoma of the breast as a presentation form.

Downloads

Download data is not yet available.

References

1. American Cancer Society. Cancer Facts & Figures 2017 [Internet]. Atlanta: American Cancer Society; 2017. [citado 13 Oct 2016]. Disponible en: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf.

2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer [Internet]. 2010 [citado 16 Ene 2017]; 127(12):2893-917. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/ijc.25516/pdf.

3. Johnson WC. Metastatic carcinoma of the skin: incidence and dissemination. In Elder DE, Elenitsas R, Johnson BL, Murphy GF, eds. Lever`s Histopathology of the skin. 9ª ed. Philadelphia: Lippincott Williams & Wilkins; 2005.p. 1149-57.

4. Hasbin Acuña P, Vial Letelier V, Correa Gutiérrez H, Lechuga Ramírez M, Pérez Rivera M, Muñoz Leyva D, et al. Metástasis cutánea de carcinoma de mama. Revisión de la literatura. Rev Chil Cir [Internet]. 2017 [citado 16 Feb 2017]; 69(1):54-88. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262017000100018.

5. Coleman RE, Holen I. Bone metastasis. In Niederhuber JE, Armitage JO, Doroshow JH,Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia: Elsevier; 2014.p. 739-63.

6. Navaratnam AV, Chandrasekharan S. Remote cutaneous breast carcinoma metastasis mimicking dermatitis Indian J Dermatol [Internet]. 2015[citado 16 Feb 2017]; 60(1):106. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318045/.

7. Siqueira VR, Frota AS, Maia IL, Queiroz HMC, Valença Jr JT, Accioly Filho JW. Cutaneous involvement as the initial presentation of metastatic breast adenocarcinoma. An Bras Dermatol [Internet]. 2014 [citado 16 Feb 2017]; 89(6): 960-3. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962014000600960&lng=en&nrm=iso&tlng=en.

8. Hoffman R, Heslop H, Furie B, Edward J, Benz EJ (Jr). Hematology: Basic Principies and Practice, Expert Consult Premium Edition-Enhanced Online Features and Print. En Hoffman´s Hematology: Basic Principles and Practice. Philadelphia: Churchill-Livingstone-Elsevier; 2014.p. 813-90.

9. Bansal R, Patel T, Sarin J, Parikh B, Ohri A, Trivedi P. Cuta¬neous and subcutaneous metastases from internal malignancies: an analysis of cases diagnosed by fine needle aspiration. Diagn Cytopathol [Internet]. 2010 [citado 16 Feb 2017]; 39(12): 882-6. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/dc.21485/pdf.

10. Chow E, Finkelstein JA, Sahgal A, Coleman RE. Metastatic cancer to the bone. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.p. 2192-2204.

11. von Moos R, Body JJ, Egerdie B, Stopeck A, Brown J, Fallowfield L, et al. Pain and analgesic use associated with skeletal relate events in patients with advanced cancer and bone metastases. Support Care Cancer [Internet]. 2016[citado 16 Feb 2017]; 24(3):1327-37. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729787/.

12. Himelstein AL, Foster JC, Khatcheressian JL, Roberts JD, Seisler DK, Novotny PJ, et al. Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial. JAMA [Internet]. 2017 [citado 16 Feb 2017]; 317(1): 48-58. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2595526.

13. Coleman R, Body JJ, Aapro M, Hadji P, Herrstedt J, on behalf of the ESMO Guidelines Working Group. Bone health in cancer patients: ESMO Clinical Practice Guidelines. An Oncology [Internet]. 2014 [citado 16 Feb 2017]; 25 (Suppl. 3): iii124–37. Disponible en: https://academic.oup.com/annonc/article/25/suppl_3/iii124/1740629.

Downloads

Published

2018-03-06

How to Cite

1.
Olivera Fonseca EM, Olivera Fonseca Y, Tamayo Ponce I, Millán Vega M. Cutaneous and bony metastases as a presentation of a breast carcinoma. RM [Internet]. 2018 Mar. 6 [cited 2025 Jun. 8];22(1):192-201. Available from: https://revmultimed.sld.cu/index.php/mtm/article/view/791

Issue

Vol. 22 No. 1 (2018)

Section

CASOS CLÍNICOS

License

Avisos de derechos de autor propuestos por Creative Commons

1. Política propuesta para revistas que ofrecen acceso abierto

Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
  1. Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
  2. Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
  3. Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).